Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
11.34
+0.29 (2.62%)
At close: May 20, 2026
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $44.82 billion as of May 20, 2026. Its market cap has increased by 72.77% in one year.
Market Cap
44.82B
Enterprise Value
82.43B
Revenue
52.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
$11.34
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 44.82B, an increase of 664.85%. That is a compound annual growth rate of 6.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 44.82B | 4.79% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 856.48M |
| Veradigm | 807.98M |
| Nika Pharmaceuticals | 536.36M |
| CytoDyn | 473.57M |
| Northwest Biotherapeutics | 417.10M |
| Elite Pharmaceuticals | 371.58M |
| American Oncology Network | 337.32M |
| Comjoyful International Company | 214.99M |